NXS 9.09% 30.0¢ next science limited

Tomorrow is the presentation. It will be an interesting...

  1. 148 Posts.
    lightbulb Created with Sketch. 119
    Tomorrow is the presentation. It will be an interesting presentation, no doubt.
    It will either validate what management has reiterated last quarterly (that we will be EBITDA +ve and Cashflow +ve by this H2 2025) or it will completely be off the mark and we get further delays to break-even.

    Given that in the previous Quarterly they reiterated guidance, this quarterly should at least show some improvements in CF. If the results do not show a slowing and closing of the gap to break-even, then I think the new management would have lost some credibility by lying through their teeth. On the other hand, if they do show improvements as per guidelines, then I think management would have done a great job.

    Here's hoping that the $5m loan that we recently got will give us enough working capital to get us to break-even in Q3 and Q4.

    Let's see how we go tomorrow.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.025(9.09%)
Mkt cap ! $87.50M
Open High Low Value Volume
27.5¢ 30.0¢ 27.0¢ $80.09K 284.6K

Buyers (Bids)

No. Vol. Price($)
1 40000 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 9322 2
View Market Depth
Last trade - 14.47pm 24/07/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.